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Carnivores, such as the dolphin and the domestic cat, have numerous adaptations that
befit consumption of diets with high protein and fat content, with little carbohydrate con-
tent. Consequently, nutrient metabolism in carnivorous species differs substantially from
that of non-carnivores. Important metabolic pathways known to differ between carnivores
and non-carnivores are implicated in the development of diabetes and insulin resistance in
non-carnivores: (1) the hepatic glucokinase (GCK) pathway is absent in healthy carnivores
yet GCK deficiency may result in diabetes in rodents and humans, (2) healthy dolphins and
cats are prone to periods of fasting hyperglycemia and exhibit insulin resistance, both of
which are risk factors for diabetes in non-carnivores. Similarly, carnivores develop naturally
occurring diseases such as hemochromatosis, fatty liver, obesity, and diabetes that have
strong parallels with the same disorders in humans. Understanding how evolution, envi-
ronment, diet, and domestication may play a role with nutrient metabolism in the dolphin
and cat may also be relevant to human diabetes.
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INTRODUCTION
Recently, it has been demonstrated that healthy Atlantic bottlenose
dolphins (Tursiops truncatus) exhibit metabolic changes after fast-
ing that are similar to those observed in humans with diabetes,
including an elevation in fasting plasma glucose concentration
(1, 2). The domestic cat (Felis catus), another obligate carnivore,
exhibits metabolic characteristics during fasting that are similar to
those observed in dolphins. A clinical syndrome of diabetes melli-
tus described in pet cats has been proposed as a model for human
diabetes (3). In contrast with the dolphin and other marine mam-
mals, glucose metabolism has been extensively studied in the cat
under various conditions including clinically normal cats, obese
cats, and cats with diabetes. Lessons learned from species such as
the dolphin and the domestic cat may cast light on general meta-
bolic pathways that have evolved to meet the unique glucose needs
of carnivores as well as the defects in metabolism that contribute
to diabetes development and progression in humans.
This article focuses on the similarities between the adaptive
metabolism of carnivores and important features of diabetes
pathology in humans. The objectives were to: (1) review adapta-
tions in nutrient metabolism that have appeared during evolution
in mammals that consume a meat-based diet that is naturally
low in carbohydrate; (2) examine parallels between select meta-
bolic features of normal carnivores and metabolic disturbances
observed in humans with diabetes; (3) discuss the usefulness of
carnivore species as diabetic models.
OVERVIEW OF CARNIVORE CARBOHYDRATE ADAPTATIONS
DEFINITION OF “CARNIVORE”
For purposes of the following discussion, “carnivore” is used to
describe any animal that consumes a diet composed of at least 70%
animal tissue (4). While many familiar carnivores (e.g., obligate
carnivores, such as felids, or scavengers, such as hyenas) are tax-
onomically grouped in the family Carnivora, some Carnivora
species are distinctly omnivorous (some dog and bear species, for
example) or even herbivorous (the giant panda) in their diet pref-
erences. When defined by diet, phylogenetically diverse mammals
such as dolphins and whales (family Cetacea) and insectivorous
bats (family Chiroptera) are also carnivores.
FELINE ADAPTATIONS TO CARNIVORY
The domestic cat is among the most extensively studied carnivores
and serves as a representative model for metabolic adaptation
to carnivory. Numerous anatomic, behavioral, and physiologic
adaptations have appeared during feline evolution as a result of
pressures imposed by the nutritional needs and feeding ecology of
cats (5). Underlying the obvious anatomical features and behav-
ioral traits that serve cats in their ecological role as apex predators
are less obvious but equally important physiologic and metabolic
adaptations. Feline adaptations to carnivory have been reviewed in
detail by others (6–8) but a brief summary of the species’ unique
adaptations related to carbohydrate metabolism is presented in
the next section.
Cats do not exhibit a preference for sugars in the diet and at
least one gene needed to detect the “sweet” taste is not expressed
(9–11). The molecular basis for taste loss is disruption and pseudo-
genization of the tas1R2 gene, which encodes one subunit of a
heterodimeric sweet receptor (11, 12). Analysis of sweet taste pref-
erences and tas1r gene isoforms from six carnivores (one felid and
five non-felids) showed that only the felid (Asiatic lion) showed no
taste preferences when offered water or water with added sweet-
ener (13). The lion tas1R2 gene, like the same gene in the cat, is
a pseudogene (13). The same microdeletion in exon 3 of tas1R2
is conserved in the domestic cat, Asiatic lion, cheetah, and tiger
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(12, 13). Additional taste loss is observed in pinnipeds (seals and
sea lions), all species of which are carnivores. In eight pinniped
species examined, the tas1R3 gene was found to be a pseudogene
(14). Lack of tas1R3 prevents formation of the unami receptor,
a heterodimer of tas1R1 and tas1R3 that detects the savory taste
(unami) in protein-rich foods (15). The relationship between a
carnivorous diet and the evolutionary loss of sweet taste is under-
scored by the observation that canids, which are close phylogenic
relatives of seals but are not obligate carnivores, retain the sweet
receptor.
Other features of feline metabolism that are relevant to car-
bohydrate metabolism have been determined from physiology
studies. Cats are reported to lack salivary amylase, which is nec-
essary for initiating digestion of some forms of carbohydrate
(16). Although cats are able to digest and absorb carbohydrates,
including simple sugars, the literature contains reports that show
cats have reduced activities of pancreatic amylase and intesti-
nal disaccharidases when compared to other species (9, 17–19).
Interestingly, certain important features of feline intestinal carbo-
hydrate digestion and absorption, such as carbohydrate transport
and disaccharidase activity, appear non-adaptable in the face of
fluctuations in dietary carbohydrate content (20). Despite the
unique adaptations observed in cats, it is clear that cats can effi-
ciently digest carbohydrates. Diets containing >40% digestible
carbohydrate can be tolerated by cats. Digestibility of most sugars
is >90%, including simple dietary carbohydrates, such as glucose
and fructose (20, 21).
PROTEIN METABOLISM IS LINKED TO GLUCOSE METABOLISM
The dietary protein requirement for carnivores exceeds that of
omnivores and herbivores (22). In “hypercarnivores,” such as
the domestic cat and dolphin, the percentage of dietary protein
is at least 70% when animals ingest a natural, prey-based diet
(4). The metabolic adaptations of cats with respect to protein
metabolism have been studied in greater detail than in other car-
nivores. Like most mammals, cats must derive essential amino
acids from the diet but strict carnivory poses special problems.
Specific and unique requirements for arginine and taurine in
cats illustrate the dietary inflexibility imposed during evolution
on strict carnivores. Unlike most mammals, cats are unable to
synthesize arginine, a vital intermediate in the urea cycle, and
as a result have an absolute requirement for dietary arginine.
However, the cat is exquisitely sensitive to arginine deficiency.
Without dietary arginine the urea cycle does not function and
the accumulation of nitrogenous byproducts results in the rapid
development of hyperammonemia (within hours), which may
be fatal (23). Along with a high dietary protein requirement,
cats also have comparatively greater nitrogen loss and hepatic
activities of catabolic enzymes than non-carnivores (22). Sen-
tinel studies by Rogers et al. established a paradigm for feline
protein metabolism that was challenged only recently (24). The
early work of Rogers et al. showed that the rate of protein metab-
olism did not vary with dietary protein content in cats (24). Based
on recently published reports, it now is clear that activities of
pyruvate carboxylase, fructose-1,6-bisphosphatase, and glucose-6-
phosphatase (G6Pase) do modulate in response to dietary protein
content but enzyme adaptation is incomplete when dietary protein
is below required minimum content (about 15% metabolizable
energy in cats) (25, 26).
Protein metabolism in carnivores is intimately linked to hepatic
glucose metabolism because protein catabolism provides sub-
strates that channel into gluconeogenic pathways. The strong
interdependent relationship between these two pathways is pos-
tulated to have evolved as a means to provide glucose needed to
maintain brain function in the face of low dietary availability of
carbohydrates (8, 27). With respect to body size, the brain of felids
is proportionately large and as a result, consumes a higher por-
tion of glucose when compared to non-felids of similar size (8).
Allometric scaling of the brain has occurred over the course of
dolphin evolution, too. The dolphin has an encephalization quo-
tient (a measure of the brain to body size that allows comparison
between different species) that is surpassed only by humans and
non-human primates (28). The continuous need for glucose to
provide substrate for oxidation reactions that supply energy for
neuronal function requires either a constant source of absorbable
carbohydrate or sustained endogenous production of glucose via
breakdown of stored carbohydrate (glycogenolysis) or de novo
production from non-sugar substrates (gluconeogenesis). Lack-
ing substantial dietary carbohydrate, cats use dietary protein to
supply brain energy needs via the latter mechanisms (8).
The need for large amounts of glucose to fuel brain function not
only requires a continuous source of glucose, but has led to adapta-
tions that improve glucose delivery to the brain. There is evidence
from dolphins and related toothed whales (odontocetes) for the
presence of erythrocyte adaptations the support transport of large
amounts of glucose in the blood (2). In most mammals, erythro-
cyte glucose concentrations are lower than the plasma concentra-
tion, but in odontocetes, humans, and non-human primates, rapid
transmembrane glucose uptake by erythrocytes produces equiva-
lent intracellular and plasma glucose concentrations (29). Glucose
uptake in the erythrocytes of dolphins is GLUT 1-mediated as in
humans (30). GLUT 1 is a widely expressed member of the GLUT
family of mammalian sugar transport proteins. GLUT 1 is a high
affinity transporter that widely expressed in cells,particularly those
that depend on glucose for energy, such as the brain and RBCs
(31). The high affinity for glucose means that GLUT 1 activity
is saturated at basal blood glucose concentration (about 5 mM in
mammals), so it is the amount of GLUT 1 expressed on the plasma
membrane that is the principal determinant of a tissue’s transport
capacity (31). It is not known whether the erythrocytes of all car-
nivores are similar to those of dolphins. As a marine mammal, the
same erythrocyte adaptations that permit large capacity glucose
transport may provide additional physiologic advantages, such as
supplying fuel during prolonged dives, which are not required
by terrestrial carnivores. Further, the Tursiops EQ is among the
highest found in mammals outside of humans and is higher than
many non-human primates (28, 32). The cat EQ, however, is about
fourfold smaller than the dolphin (33). The very high EQ of the
dolphin and related odontocetes may impose additional demands
on glucose availability than those of the cat, despite the relatively
large brain of felids.
Hepatic carbohydrate metabolism of cats has several character-
istics that distinguish it from metabolism of non-carnivores but
are not necessarily unique. A principal feature of feline hepatic
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glucose metabolism is the absence of glucokinase (GCK) activity
and the predominance of low Km hexokinase (HK) activity (34,
35). The enzyme pattern in the liver of the cat is not unique among
mammals or even among carnivores. There are four mammalian
hexokinases (identified as HK I–IV; HK IV is also known as GCK)
that are expressed in various patterns in the liver but a particu-
lar pattern is not always consistent within taxonomic Orders [for
summary, see Ref. (36)]. For example, the hexokinase pattern is
variable between members of Carnivora, while the pattern is rel-
atively consistent in Artiodactyla. In cat liver, hexokinase I and II
are present but GCK is absent. The pattern in the cat is identical
to a bat from a separate phylogenic order (Carnivora and Chi-
roptera, respectively) but differs from that found in the dog (HK
I, HK II, and GCK), also in the order Carnivora. The spectrum of
hexokinases present in the liver likely has functional consequences,
particularly the presence or absence of GCK (HK IV). Studies of
hexokinase distribution established that the lack of hepatic GCK is
more consistent with the dietary preference of a particular species
than with the evolutionary relationship between species. The rela-
tionship between GCK and diet preference is borne out in lower
vertebrates, too. The barn owl and trout, both carnivores, also
lack hepatic GCK (37, 38). It is of interest to note that induc-
tion of hepatic GCK activity after feeding a high carbohydrate diet
has been shown to occur in trout and chicken, species previously
reported to lack hepatic GCK (39, 40), but induction has not been
studied in the cat.
Gluconeogenesis in the non-carnivore liver is activated during
fasting and starvation and is inhibited by nutrient and hormone
signals from the gut after a meal (40). In the cat, hepatic gluco-
neogenesis is reported to be continually active (24). Consistent
with the need for a high gluconeogenic capacity, the activity of
the G6Pase enzyme system is comparatively high in feline liver
compared to canine liver as are activities of other rate limiting
gluconeogenic enzymes, pyruvate carboxylase, and fructose-1,6-
bisphosphatase (24, 34, 35). The mink (Mustela vison), an obligate
carnivore, also exhibits active hepatic gluconeogenesis. In fact,
activities of G6Pase and PEPCK are higher than measured in cat
liver (41). Comparatively, gluconeogenic enzyme activity in both
the cat and mink exceed activity in rat liver (41).
Rates of gluconeogenesis and protein catabolism in the feline
liver do not adjust completely to changes in dietary composition
(24–26). The constant requirement for substrate to supply high
rates of protein oxidation and gluconeogenesis is hypothesized to
underlie the high dietary protein requirement of cats. Several lines
of evidence now indicate that feline hepatic metabolism is capa-
ble of being regulated by dietary components. An in vitro study
with isolated hepatocytes obtained from cats fed diets of different
protein composition showed a parallel increase in protein oxida-
tion rates and protein intake, although the gluconeogenic rates did
not vary with protein intake (42). Tracer and indirect calorime-
try studies, respectively, revealed enhanced glycogenesis in liver of
cats in response to a rise in the insulin level (43) and increased
glycogen and lipid production along with enhanced glycolysis in
lean cats under euglycemic clamp (44). Recent work using in vivo
nuclear magnetic resonance (NMR) to study adaption to obesity
and diet yielded unexpected results. Despite insulin resistance and
impaired glucose tolerance, chronically obese cats exhibit lower
hepatic glucose production during fasting than lean counterparts
(45, 46).
CARNIVORE HEPATIC GLUCOSE-SENSING PATHWAYS
The hepatic glucose-sensing pathway, which is important for nor-
mal glucose homeostasis and disordered in diabetes, has been stud-
ied at the molecular level in the domestic cat. The hepatic glucose-
sensing pathway illustrates how normal carnivore metabolism may
inform understanding of the abnormal glucose metabolism that
characterizes the diabetic state.
THE CONCEPT OF GLUCOSE SENSING
In mammals, blood glucose concentration is maintained within
narrow physiologic limits by balancing glucose entry into the cir-
culation with its removal by the tissues. Regulatory mechanisms
are needed to ensure an adequate supply of glucose to tissues,
such as the brain, that require high amounts of glucose for nor-
mal function and to guard against detrimental fluctuations in
glucose concentrations. The endocrine pancreas (islets of Langer-
hans) and liver are major organs involved in blood glucose sensing,
but important roles are hypothesized for specialized neurons in
the brain and enteroendocrine cells in the gut. Precise minute-to-
minute regulation of insulin secretion from the pancreatic beta
cells requires a glucose-sensing mechanism to modulate beta cell
function according to the prevailing glucose concentration, while
glucose-sensing pathways in hepatocytes ensure proper balance
between hepatic glucose usage and production (47). Central to
both glucose-sensing mechanisms is the concept of a molecular
“glucose sensor” as the principal regulator of cellular glucose flux
and, thus, the generation of downstream signals that adjust cellular
function (47).
An important molecular pathway involved in mammalian
glucose-sensing involves the enzyme GCK. Mammalian GCK, the
protein product of the highly conserved GCK gene, is found only
in glucose-responsive tissues where it is the de facto “glucose sen-
sor” (48). GCK is present as a single copy in mammalian genomes
under the control of two separate promoters (49). The “neu-
roendocrine” (or “pancreatic”) promoter controls expression in
pancreatic islet cells and specialized cells in the gut and hypothal-
amus (48, 49). The second promoter, the “hepatic” promoter, is
active only in hepatocytes (48, 49). The major GCK mRNA iso-
forms present in pancreas and liver differ at the 5′-UTR and exon
1; the remainder of the mRNAs containing exons 2–10 and the
3′ regions are identical (48). Minor mRNA isoforms with alter-
nate first exons have been found in human and rat liver (50, 51),
suggesting the pattern of hepatic GCK expression may vary in
some species. Differential GCK expression by hepatocytes and
pancreatic endocrine cells conveys the ability to vary the meta-
bolic response according to the blood glucose concentration (49).
The importance of GCK expression for maintenance of glucose
homeostasis and as a crucial component of glucose-sensing and
metabolic regulation has been firmly established in experimental
and clinical over the past several decades, including the study of
naturally occurring GCK mutations of humans (52).
GLUCOSE SENSING IN THE PANCREAS
A complete review of the cellular pathways involved in the beta
cell response is beyond the scope of this article but these pathways
www.frontiersin.org December 2013 | Volume 4 | Article 188 | 3
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Schermerhorn Carnivore carbohydrate metabolism
have been well established in human and rodent beta cells and
in insulin-secreting cell lines (53–56). GCK as an important and
essential component of beta cell glucose sensing is supported by
a large body of evidence from overexpression studies (57), site-
directed mutagenesis (58, 59), and study of naturally occurring
mutations (60, 61), knockout models (62–64), and pharmacologic
manipulation of GK function (65, 66).
Although detailed studies are lacking, the pancreatic glucose-
sensing mechanism is likely to be fundamentally similar in carni-
vores and non-carnivores. GCK mRNA has been detected in the
feline pancreas (7, 35, 66) and in an insulin-producing pancreatic
tumor from a cat (7). GCK activity in normal feline pancreas
has yet to be confirmed. However, in a cat with a functional
insulin-producing tumor and hypoglycemia, tumor GCK expres-
sion was nearly 17 times greater than normal pancreatic tissue
from the same cat, suggesting a relationship between the mag-
nitude of GCK expression and insulin secretion, similar to that
observed in in vitro overexpression studies (7). Feline islets also
express numerous other genes with roles in insulin signaling (67).
Furthermore, pharmacologic treatment with arginine (68, 69), sul-
fonylureas (70), or exenatide (a GLP-1 mimetic) (71) also elicit the
expected increase in insulin secretion in cats. At present, there is no
evidence that beta cell glucose-sensing or stimulus secretion cou-
pling differ between carnivores and non-carnivores. When viewed
in light of results from in vivo clinical and experimental studies
of glucose-stimulated insulin secretion in cats, the importance of
glucose as a major physiological stimulator of insulin secretion in
cats is affirmed.
OVERVIEW OF HEPATIC GLUCOSE SENSING
In non-carnivore models, including rodents (72) and dog (73, 74),
a network of interacting hepatocellular proteins serves to sense
changes in glucose and other nutrients after a meal and initiates
the appropriate metabolic response. The“fasted-to-fed”metabolic
transition in the liver is mediated by nutrients, especially carbo-
hydrates, and hormones, especially insulin and glucagon (40). In
the fasted state, when blood glucose and insulin concentrations are
basal, the insulin:glucagon ratio favors hepatic glucose production
via gluconeogenesis. After ingestion of a carbohydrate-containing
meal and stimulation of pancreatic insulin secretion, the combi-
nation of elevated portal glucose concentration and the increased
insulin:glucagon ratio promotes hepatic glucose uptake via stim-
ulation of GCK activity and simultaneously reduces hepatic glu-
coneogenesis via inhibition of G6Pase activity. Circulating hor-
mones and nutrients produce their effects on hepatic function
by directly altering protein interactions and enzymatic activity
but exert equally important long term effects on hepatic glucose
metabolism by influencing the expression of genes involved in the
glucose-sensing network.
Molecular glucose sensing in the non-carnivore liver
Hepatic GCK activity is influenced by nutritional status and acute
changes are observed soon after feeding. Dietary nutrients, espe-
cially glucose and fructose, acutely stimulate hepatic GCK activity.
Within individual hepatocytes, GCK activity is also regulated
by the glucokinase regulatory protein (GKRP), which is local-
ized in the hepatocyte nucleus. GCK undergoes a well-described
nuclear-cytosolic translocation cycle and its subcellular localiza-
tion varies with the nutritional state (75). In the fasted state,
GCK is bound to GKRP and localized within the hepatocyte
nucleus, where it is functionally inactive (76). After feeding, GCK
translocates to the cytosol and becomes enzymatically active (76).
GCK entry into the nucleus requires GKRP but exit from the
nucleus is mediated by a nuclear export signal in the GCK amino
acid sequence (77). The GCK/GKRP regulatory unit provides a
mechanism for hepatocyte metabolism to respond to demands
for increased glucose phosphorylation. There are strong recip-
rocal control effects of glucose phosphorylation (GCK exerts a
positive effect; GKRP exerts a negative effect) and GCKR over-
expression inhibits glucose phosphorylation and decreases GCK
activity (78).
Molecular glucose sensing in the carnivore (feline) liver
Although feline genes involved in glucose metabolism appear to be
highly conserved (79–81), work in cats has clearly demonstrated
that the molecular basis of feline hepatic glucose-sensing differs
from the model defined in the non-carnivore liver (82). GCK and
GCKR (the gene that encodes GKRP) mRNAs are absent from
feline liver and activities of GCK and GKRP proteins are not
detectable (35, 38, 82). The cat appears to be a naturally occurring
model for GCKR knockout. The phenotype of transgenic GCKR
knockout mice is normal (normal blood glucose and no evidence
of diabetes). However, like the cat, GCKR knockout mice are sus-
ceptible to stress-induced hyperglycemia and exhibit mild glucose
intolerance compared with wild-type that express GCKR (83).
Heterogeneous or homogeneous GCKR knockouts show reduced
liver GCK activity (83).
Lack of GCK and GKRP suggests that feline liver cannot
respond incrementally to physiologic changes in blood glucose. In
the absence of GCK, the initial glucose phosphorylation step must
be performed by another hexokinase (e.g., HK I). The kinetic fea-
tures (high affinity, low Km) of hexokinase I means that enzyme
activity will be maximal at glucose concentrations below the basal
blood glucose concentration and cannot increase its rate of glu-
cose phosphorylation in the face of increasing blood glucose levels
(e.g., after a meal). However, GKRP has effects on GCK gene and
protein levels distinct from its action as a regulator of GCK activ-
ity. Thus, the lack of GCKR expression in cats may contribute to
reducedGCK mRNA expression and low enzyme activity observed
in feline liver as was shown for mice with GCKR knockout (84).
Hepatic expression and activity of fructokinase (KHK gene),
which metabolizes fructose and serves as an upstream regulator
of GK:GKRP binding, is preserved in the cat. Although fructose
can be digested and absorbed by cat intestine (20), it is some-
what unexpected to find that fructokinase activity in feline liver
is comparatively higher than in canine liver (35). The reason for
abundant fructokinase expression in the feline liver is not clear
since fructose, a simple sugar, is not expected in substantial quan-
tity in a carnivore diet. KHK is widely expressed in feline tissues,
including tissues (e.g., spleen) that have no role in nutrient metab-
olism (80). A similar pattern of KHK expression was previously
defined in non-carnivore mammals (85), which led investigators
to hypothesize possible roles for KHK in cell function in addition
to its role in dietary fructose metabolism (85, 86).
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The importance of GCK expression for normal glucose metab-
olism has been established beyond doubt by transgenic and gene
knockout studies and the study of naturally occurring GCK muta-
tions in humans [reviewed by Osbak et al. (52)]. Transgenic mice
and in vitro studies show that even small reductions in the level
of GCK expression can have dramatic negative impact on glucose
sensitivity while GCK overexpression generally enhances glucose
sensitivity (87). Transgenic mice with global GCK loss or targeted
disruption of islet GCK expression are diabetic at birth and die
within a few days (87). Mice with targeted disruption of hepatic
GCK are viable and do not exhibit a diabetic phenotype but have
altered glucose tolerance and display hyperglycemia under stress
conditions (87).
Over 600 naturally occurring mutations in GCK have been
described (52). Activating mutations are associated with hyper-
insulinemia and hypoglycemia, which lead to a group of syn-
dromes commonly referred to as congenital hyperinsulinemias
(CHI). Inactivating mutations result in impaired insulin release
and hyperglycemia and are associated with familial forms of
diabetes. GCK mutations cause a monogenetic form of human
non-insulin dependent diabetes known as Maturity Onset Dia-
betes in the Young (MODY). Each MODY subtype (there are
five subtypes) results from mutation of a gene involved in glu-
cose metabolism;GCK mutations cause MODY type 2 (MODY2),
which account for as many as 60% of all MODY cases (7). Along
with its causative role in MODY-GCK, a monogenic form of dia-
betes, GCK has long been suspected as a candidate gene with a
role in the development of other forms of diabetes mellitus, too.
Although several investigations have linked GCK mutations and
polymorphisms to human type 2 diabetes, at present a clear role for
GCK in the development of human type 2 diabetes has not been
demonstrated (88–90). No disturbances of glucose metabolism
due to GCK mutation have been reported in dolphins, cats, or any
other wild or domestic mammals, however, newer technology for
rapid, inexpensive sequencing of individual genomes may render
discovery of such mutations more likely in the future. Identifica-
tion of genetic polymorphisms and study of naturally occurring
mutations can provide valuable insight into the functional role of
genes in glucose metabolism pathways of carnivores.
Although reduced capacity for metabolism of simple sugars is
consistent with consumption of a low carbohydrate diet, in light
of the importance of GCK expression in humans and rodents, the
complete lack of hepatic GCK activity remains difficult to reconcile
from a physiological perspective. For example, GCK expression
has been demonstrated to be crucial for coordination and regu-
lation of hepatic glycolysis and lipogenesis in mouse hepatocytes
(91). In the absence of GCK, glucose phosphorylation in hepa-
tocytes is catalyzed by HK I, a hexokinase with kinetic features
that render it unsuitable as a replacement for GCK. GCK shows
an activity curve that increases with the glucose concentration
and activity is nearly linear over the physiologic range of glucose
(92). HK I activity is maximal at basal glucose concentration and
the enzyme is unresponsive to changes over the physiologic range
(92). Further, unlike GCK, HK I is inhibited in the presence of its
reaction product, G-6-P, which is continually produced by gluco-
neogenesis in feline hepatocytes (92). Thus, the most frequently
proffered explanation that lack of GCK expression is overcome by
upregulation of HK activity is unlikely from a biochemical per-
spective and lacks mechanistic detail. A clear challenge for future
research seeking to understand carnivore carbohydrate metab-
olism is determination of the mechanism(s) by which hepatic
glucose phosphorylation can proceed efficiently in the absence of
GCK. Until carnivore studies become available, results from trans-
genic studies that aimed to ameliorate diabetes in rodent models
suggest possible mechanisms.
Activation of glucose disposal pathways that are distal to the
GK-mediated phosphorylation step promotes hepatic glycolysis
and glycogen synthesis; some of these improvements occur even
when GK activity is nearly absent (40). Overexpression of Protein
Targeting to Glycogen (PTG) in 3T3 LI cells or rat hepatocytes
increases glycogenesis (93, 94). Interestingly, glycogen synthesis in
rat hepatocytes overexpressing PTG is glucose and insulin inde-
pendent and continues even when glucose is excluded from culture
media (94). Lacking glucose, carbon incorporated into glycogen
is likely contributed by gluconeogenic pathways (94). The results
from expression studies suggests that PTG-mediated activation of
glycogenesis is one possible mechanism by which feline hepato-
cytes could synthesize glycogen when the dietary glucose concen-
tration is low, yet there are high concentrations of gluconeogenic
precursors.
The action of glycogen targeting proteins may inform another
important but unanswered question regarding feline hepatic car-
bohydrate metabolism. Several studies have concluded that the
improved glucose utilization and glycemia observed in diabetic
models when PTGs are overexpressed is due to a “pull” effect that
redirects G-6-P away from gluconeogenic pathways and into glyco-
gen synthesis (40). The same improvements are observed in the
SMZ-induced diabetic rat model in which GK activity is very low
(95). In the latter model, it may be that the enhanced flux of G-6-P
through glycogenic pathways is enough to disinhibit hexokinase I
and permit an increase in the glucose phosphorylation rate (95).
Comparative overexpression of PTGs is a possible mechanism
to explain how the feline liver could continue to funnel glucose
through the G-6-P pathway despite the lack of GCK expression.
Despite the low carbohydrate content of the natural feline diet,
glycogenic pathways are fully functional in feline hepatocyte. A
recent report stating that the glycogen storage capacity in feline
liver is comparable to that of non-carnivores (dog and human)
(96) lends support to the possibility that PTGs may make enough
G-6-P available to support robust glycogenesis. While it is intrigu-
ing to contemplate the involvement of PTG-mediated pathways in
the feline glucose metabolism, the expression of PTG and related
proteins in carnivore hepatocytes and their role(s) in modulating
glycogenesis remains an unexplored area that awaits investigation.
IS THE CAT A REPRESENTATIVE MODEL FOR CARNIVORE GLUCOSE
SENSING?
The lack of GCK and GCKR expression in liver of the domestic cat
has been convincingly demonstrated. But is the lack of expression
of these genes unique to the cat or is it a universal feature of car-
nivore metabolism? Direct determination of GCKR expression or
activity in vertebrate liver has not been widely explored. A study
by Vandercammen and van Schaftingen (38) showed that species
(cat, trout, cow, goat, chicken) that lacked GCK activity also lacked
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GKRP activity. Recently, Wang el al. (97) used bioinformatics to
examine the GCKR gene in the genomes of carnivore and non-
carnivore species. Using published gene sequences and available
genomic assemblies to predict gene sequences, it was found that
GCKR was intact in most non-carnivore species. However a vari-
ety of GCKR mutations were found in the genomes of mammalian
carnivores, including the cat and dolphin (97). Feline GCKR was
predicted to have frame shift mutations in three separate exons
(exons 2, 4, and 10) and a splice mutation in exon 2. GCKR in Tur-
siops had predicted frame shift mutations in seven exons (exons
1, 3, 4, 6, 9, 15, and 19) and a splice mutation in exon 1 (97). At
least one mutation that is likely to disrupt GCKR coding is present
in species that have confirmed absence of hepatic GCK expression
or activity. However, no single mutation is shared by species with
inactivated GCKR. A recent survey of GCK gene structure in all
carnivore and non-carnivore species for which genome sequences
are available concluded that GCK is a highly conserved (81). It
was predicted that GCK is a functional gene (if expressed) in all
of the mammals examined (81). The finding that GCK is con-
served and predicted to be functional in carnivores, led Wang et al.
to hypothesize that it was the presence of mutations that disrupt
GCKR expression that lead to a parallel loss of GCK expression in
carnivores (97). The genetic mechanism(s) linking the two genes
is unknown but is likely to be complex. The consistent loss of
GCKR and GCK in carnivore species suggests the change is adap-
tive. The observation that different mutations produce a common
phenotype in different carnivores suggests GCKR mutations arose
separately during evolution. In the cat and dolphin (and likely
other carnivores), separate genetic events leading to the evolu-
tionary loss of GCKR likely represents independent adaptations
to carnivory. Like GCKR, other hepatic genes with metabolic roles
appear to have adapted to serve carnivore metabolism during evo-
lution of carnivory (98, 99). Despite the apparent convergence
of molecular mechanisms for carbohydrate metabolism observed
in carnivores of different phylogenic origins, the possibility that
individual carnivore species have evolved unique mechanisms in
response to metabolic challenges should not be dismissed and
emphasizes the continued need for species-specific investigations.
“DIABETES PATHOLOGY” IN NORMAL CARNIVORES
Normal glucose and protein metabolism of carnivores affects
serum glucose and insulin in ways that resemble diabetes pathol-
ogy in humans. Of course, nutrient metabolism observed in
healthy carnivores, such as dolphins and cats, is “abnormal” or
unusual only when compared with the same metabolic processes
in non-carnivores. When viewed from a non-comparative perspec-
tive, carbohydrate and protein metabolism of healthy carnivores
reflects processes which have appeared during evolution as adap-
tations to the consumption of diets naturally low in carbohydrate.
In addition, some domesticated and captive carnivores develop
pathologic conditions with similarities to human diabetes. Results
of carnivore studies highlight the potential of these animals to be
natural models for the study of common pathologies associated
with human diabetes (1, 3, 100).
“GLUCOSE INTOLERANCE” IN HEALTHY CATS AND DOLPHINS
It is reported that the bottlenose dolphin, T. truncatus, demon-
strates comparatively high fasting blood glucose levels and exhibits
prolonged glucose clearance compared with the same measures in
humans (1, 2). These features of dolphin carbohydrate metabolism
have parallels in the healthy cat, another obligate carnivore that
exhibits mild carbohydrate intolerance after a glucose challenge
and is prone to develop physiologic hyperglycemia (101, 102).
Venn-Watson and Ridgway (2) carried out hematologic and
biochemical analysis of a large number of blood samples (n∼ 1100
samples) obtained from Atlantic bottlenose dolphins that revealed
significant differences between non-fasted (meal consumed within
previous 6 h) or fasted (meal withheld for 10–14 h) conditions.
In fasted dolphins, a slight but significant increase in glucose
was detected. Fasted samples also had elevated platelet count,
chloride and creatinine concentrations, and increased activities
of serum alkaline phosphatase, gamma-glutamyl transferase, and
creatine kinase. Fasting decreased serum concentrations of blood
urea nitrogen, potassium, carbon dioxide, triglycerides, and uric
acid. Changes in glucose, uric acid, GGT, ALP, platelet count, and
acid-base indicators observed in fasted samples paralleled changes
observed in humans with diabetes. A follow-up study by the same
investigators examined dynamic glucose responses in dolphins fed
either a dextrose solution or a fish meal (1). Both meals elevated
serum glucose for 5 h post-ingestion but glucose remained elevated
over baseline for up to 10 h in dolphins that ingested the dextrose
solution. Along with delayed return to baseline, the peak mean
glucose concentration at 5–10 h following dextrose ingestion was
nearly 40% greater than that observed after the fish-based meal
(209 versus 124 mg/dL, respectively) (1). Insulin and glucagon
responses to a protein meal were determined in five male and
female dolphins ranging in age from 8 to 48 years. Mean basal
insulin in this group was ∼12µIU/ml but mean insulin 2 h-post-
prandial was lower (∼9µIU/ml) (1). These data are difficult to
interpret because insulin levels in this small group showed sub-
stantial variability, particularly the post-prandial measurements,
possibly due to influences of gender and age, as noted for other
hematologic and biochemical parameters (103). Further study
with larger groups and uniform populations is needed to place
these initial findings into context.
Oral glucose challenge tests with healthy dolphins yielded
results that strongly suggest glucose intolerance when compared
to similar challenges with non-carnivore species (1). First, mean
blood glucose after a dextrose challenge took as long as 10 h to
return to baseline in healthy dolphins. The time course to return
to baseline after glucose challenge in the dolphin is much longer
than expected in a human, rodent, or dog. Second, examination
of blood glucose curves from individual dolphins given dextrose
showed a rapid rise in glucose that reached peak concentration
4–8 h after ingestion. In contrast, glucose decreased hourly for
5–10 h after ingestion of a mackerel meal. Lastly, peak glucose
concentrations achieved after dextrose ingestion in the dolphin
are compatible with mild diabetes and were accompanied by an
eightfold increase in urine glucose concentration, another feature
of overt diabetes in humans.
Insulin and glucose responses have also been studied in cats
fed diets containing various amounts of carbohydrate. Because
commercial feline diets, even those with abundant carbohydrate
content, contain very low amounts of simple sugars, such as glu-
cose and fructose (104), glucose concentrations may rise slowly
after a meal as complex carbohydrates undergoes the digestive
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process (105). As a result the post-prandial glycemic response
remains poorly defined in cats with some studies reporting a
blunted post-prandial hyperglycemia (21, 106). Intravenous infu-
sion of large amounts of glucose (up to 1 g/kg body weight)
induces a rapid rise in blood glucose and invokes insulin secretion.
Intravenous glucose tolerance tests have typically shown delayed
glucose clearance in normal cats (about 90 min) compared with
dogs (about 40–60 min) and humans (30–40 min) (105, 107). The
IVGTT produces a rapid glucose change that would not occur
if the cat were consuming its natural diet. In bypassing the oral
route, the IVGTT response does not account for potential contri-
butions from gut hormones, such as GLP-1, to enhance the insulin
secretory response. An interesting study by Hewson-Hughes et al.
attempted to sidestep the inherent problems associated with pre-
vious approaches by comparing the glycemic response of a high
protein diet with the same diet that had been “glucose-loaded”
by the addition of d-glucose (105). Cats that ate the high protein
diet+ glucose showed markedly different post-prandial glucose
and insulin patterns than did control cats that ate the unaltered
diet. Cats consuming the glucose-loaded diet experienced large
and sustained increases in glucose,with a mean peak concentration
of∼180 mg/dL (5 mM) and a 5- to 6-h duration of hyperglycemia.
Curiously, despite marked hyperglycemia it produced, the glucose-
loaded diet elicited a weak insulin secretory response, although
insulin concentration still exceeded that recorded in cats eating
the high protein diet without added glucose (105). Hyperglycemia
in the diet+ glucose group could develop as a result of insulin
resistance, impaired hepatic glucose uptake, unsuppressed hepatic
glucose output, or a combination of factors. The weak insulin
secretory response to dietary glucose was unexpected and is unex-
plained considering that adequate insulin responses have been
observed in cats consuming diets of varying carbohydrate compo-
sitions. It is unlikely that diminished pancreatic glucose-sensing
accounts for the sluggish insulin response in the cat, but the finding
deserves closer study.
In summary, post-prandial serum glucose and insulin fluctu-
ations observed in healthy dolphins and cats would be consistent
with mild degree of glucose intolerance if the same changes were
found in non-carnivore species. Caution is warranted when com-
paring glucose tolerance between healthy individuals of different
species (e.g., human versus dolphin). Such comparisons are useful
and can inform understanding of normal carbohydrate metabo-
lism for a particular species but differences should not be inter-
preted to imply pathology in one or the other species. The value in
gaining and understanding of the mechanisms that govern glu-
cose and insulin responses in healthy carnivores is the insight
provided into the possible pathologic mechanisms that produce
similar changes leading to glucose intolerance in non-carnivore
species.
UNSUPPRESSED HEPATIC GLUCOSE OUTPUT
In the diabetic liver, failure of insulin to induce a switch from
glucose production to glucose utilization reflects hepatic insulin
resistance (108–110). The blunted response to the rise in the
insulin:glucagon ratio that occurs following a meal means that
the diabetic liver continues to produce glucose in the post-
prandial period when intestinal absorption of carbohydrate is
also increased. These factors produce post-prandial hyperglycemia
which is manifest clinically as glucose intolerance.
In carnivores consuming a natural diet, the low carbohydrate
content minimizes the possibility that large changes in glucose
will occur during the absorptive phase following a meal. When
the diet contains low amounts of glucose, hepatic gluconeogenesis
is predicted to be the major pathway to maintain blood glucose.
Consistent with the latter expectation, the activities of key glu-
coneogenic enzymes (G6Pase, fructose-1,6-bisphosphatase, and
pyruvate carboxylase) are increased in the liver of normal cats (34,
35). Whole animal studies in cats have shown that endogenous
glucose production during fasting is mainly from gluconeogenesis
but glycogenolysis contributes ∼30% of total glucose produced
under fast conditions and as much as 40% in the post-prandial
period (45, 96). The finding that “stress hyperglycemia,” a clinical
phenomenon observed in pet cats presenting to veterinarians for
treatment, is caused by enhanced hepatic glucose output, rather
than insulin resistance as previously postulated, underscores the
gluconeogenic potential of the feline liver (101). There is abun-
dant evidence for robust glucose production in healthy cats during
fasting and it is possible that physiologic inhibition following food
intake is incomplete, although hepatic glucose metabolism is now
recognized to be moderated to a greater degree than previously
believed (45).
PATHOLOGIC DISORDERS OF CARNIVORES ASSOCIATED
WITH INSULIN RESISTANCE
Insulin resistance occupies a prominent pathophysiologic role in
the development and propagation of the diabetic state. Insulin
resistance can be conceptually defined as a resistance (impaired
sensitivity) to insulin action at the tissue level. Insulin resistance is
mediated at the cellular level with muscle being the most impor-
tant affected tissue, but adipose tissue and liver also affected.
Early insulin resistance is characterized by hyperinsulinemia but
not hyperglycemia. Hyperglycemia does not develop because the
reduced effect of insulin at target tissues is offset by an increase in
insulin secretion. Later, when beta cell function is impaired and
the total insulin secretory capacity falls, hyperglycemia develops
because insulin resistance is now accompanied by a relative or
absolute insulin deficiency.
In animal studies, insulin resistance is difficult to measure
directly except under carefully controlled conditions using eug-
lycemic clamp methods and is not routinely performed outside of
the research setting. The euglycemic clamp is the gold standard
used to measure insulin resistance in humans, too, but algorithms
have been developed that use simple clinical measures to identify
insulin resistant humans (111). The algorithms used in humans
were generated from a large amount of data from human clamp
studies and are not likely to be useful in other species. Lacking
similar species-specific algorithms, insulin resistance in the cat
or dolphin must be either measured using clamp methodology
(112, 113) or inferred when glucose intolerance or reduced insulin
responsiveness are detected (114, 115).
HEMOCHROMATOSIS AND FATTY LIVER IN DOLPHINS
Dolphins develop two hepatic disorders, hemochromatosis and
fatty liver, that have been associated with acquired insulin resistant
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states in humans. Hemochromatosis, also known as iron overload,
is a disorder associated with hepatic iron accumulation and severe
insulin resistance (116). Hemochromatosis occurs in humans and
has been documented in a variety of animals (117–119). Iron
overload increases serum iron and ferritin concentration; fer-
ritin increases in parallel with serum iron and can be used as
an indicator for serum iron concentration. Affected dolphins have
elevations in the serum iron and ferritin levels (120) and exhibit
elevation in serum insulin and glucagon concentrations 2-h after
feeding, consistent with insulin resistance (1). Iron overload may
have a genetic basis, which is the most common etiology of human
hemochromatosis, or may be an acquired disorder associated
with a variety of non-hereditary conditions (121). Phlebotomy
is the treatment of choice for hemochromatosis in dolphins and
the intervention successfully decreases serum iron levels (122).
Interestingly, insulin resistance – as defined by detection of persis-
tent post-prandial hyperinsulinemia – persists in treated dolphins
despite normalization of serum iron and ferritin levels (121, 122).
Fatty liver of dolphins resembles human non-alcoholic fatty
liver syndrome and hepatic lipidosis described in cats and other
veterinary species. A recent investigation that examined archived
pathology samples from 18 captive dolphins that had died over a
25-year period reported finding histological evidence of fatty liver
in nearly 40% of dolphins (116). Lipidosis was found in associ-
ation with other liver disorders (hemochromatosis and hepatitis)
in some dolphins (116). Hepatic accumulation of lipid occurs
when lipid mobilization exceeds hepatic release of lipids and is
associated with development of insulin resistance in humans with
non-alcoholic fatty liver. Fatty liver is a component of the meta-
bolic syndrome of people and is a major risk factor for diabetes
development; the occurrence of a similar syndrome in animals is
not well documented. However, the proportion of dolphins with
fatty liver that also had fasting hyperglycemia (>140 mg/mL) was
significantly greater than dolphins without fatty liver (116). Inter-
estingly, dolphins with fasting hyperglycemia and fatty liver were
also more likely to have leukocytosis and hyperglobulinemia in the
12-months prior to death than dolphins without fatty liver (116).
The presence of the latter findings suggests some dolphins with
fatty liver may develop a chronic inflammatory state that resembles
steatohepatitis, a severe manifestation of fatty liver syndromes of
humans characterized by hepatic inflammation that exacerbates
existing insulin resistance. Despite similarities between lipidosis
syndromes of dolphins and terrestrial mammals, including cats
and humans, insulin resistance has not been specifically demon-
strated in dolphins affected with fatty liver. Definitive documenta-
tion of insulin resistance and its physiologic and pathologic roles
in dolphin health and disease remains aims for future studies.
FELINE OBESITY
Feline obesity has many parallels with obesity in humans and may
serve as a model for the disorder in humans (100). Obesity has
been consistently recognized as a strong risk factor associated with
feline diabetes in epidemiologic studies, along with other risk fac-
tors such as sedentary habits, reproductive status, and assorted
environmental factors (123, 124). Yet, obesity in the cat, as in all
pet and captive animals, is not a spontaneous disorder. Rather, it is
a diet-induced disease that develops as a result of excessive caloric
intake (125). The relatively sedentary lifestyle of domesticated or
captive carnivores (e.g., pet cat or captive dolphin) has few oppor-
tunities to participate in the intense physical activity related to
chasing and catching prey, patrolling a territory, and other activ-
ities that comprise daily life for free-living individuals. Unlike
their wild counterparts, pet and captive carnivores are fed reg-
ularly and avoid extended periods of fasting and starvation, which
might occur in wild animals subject to cycles in prey availability.
Because of its dependence on the availability of excess calories,
obesity is expected to occur infrequently, if at all, in free-living
populations.
Euglycemic clamp studies in lean and obese cats consistently
show insulin sensitivity is decreased in obese cats compared with
lean cats (43–45). Body weight was the most significant factor that
affects measures of insulin resistance (45). The effect of obesity
on insulin resistance is marked and it has been estimated that
insulin sensitivity and glucose effectiveness declines by 30% for
every 1 kg increase in body weight (45). Along with the hallmark
insulin resistance, obese cats develop hormonal changes that paral-
lel those found in obese humans (45, 126). Adiponectin and leptin
are hormones produced exclusively by adipose tissue. Adiponectin
acts to improve insulin sensitivity (126) and serum concentrations
are reduced in obese, insulin resistance humans (127, 128). Serum
adiponectin is significantly lower in obese cats compared with lean
cats and rise after weight loss (45). Leptin serum concentration is
proportional to the mass of adipose tissue in humans (129) and is
elevated in obese humans, dogs, and cats (129–131). In obese cats,
the serum leptin concentration inversely correlates with insulin
sensitivity (114). When obese cats lose weight, leptin concentra-
tions decrease to a level equivalent to the leptin concentration
found in the lean cats (45).
IMPACT OF DOMESTICATION AND CAPTIVITY ON
CARNIVORE CARBOHYDRATE METABOLISM
In studies with carnivores, it is important to consider possible ways
that captivity or domestication might impact “normal” carbohy-
drate metabolism. Factors such as environment, husbandry, diet,
and ability to adapt to captivity are potential confounding factors
that must be considered when investigating carbohydrate metab-
olism using captive populations of bottlenose dolphins. Likewise,
the effects of domestication must be taken into account when using
the cat as a model for carnivore metabolism. Domestic cats live in
a research colony or as pets, consume processed diets, and have
a relatively sedentary life style compared with wild felids. Further
selective breeding, which has occurred in cats for thousands of
years, may have intentionally or unintentionally introduced traits
that alter nutrient metabolism. For example, it is possible that the
high prevalence of diabetes in pure bred Burmese cats from catter-
ies in Europe and Australia is an unintended outcome of selective
breeding since Burmese breed has not been identified as a diabetes
risk factor in the U.S. feline population (132, 133). Although the
genetic basis for the difference between the two Burmese cat pop-
ulations is not known, the observation serves to illustrate both the
ability of selective breeding to alter metabolic traits over relatively
few generations and a possible pitfall when attempting to extrap-
olate research from a domestic carnivore to the larger group of
non-domesticated carnivores (134).
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IMPACT OF CAPTIVITY/DOMESTICATION ON FASTING GLUCOSE
Variability in fasting glucose is one example of a possible effect
of captivity or confinement on metabolic measurements in car-
nivores. In three separate studies, fasting glucose in captive bot-
tlenose dolphins was determined to be between 108 and 194 mg/dL
(1, 2, 103). The largest study measured serum glucose in 1161
samples from 52 captive bottlenose dolphins and reported mean
serum glucose concentrations of 108 and 112 mg/dL in fed and
fasted conditions, respectively (2). A second study was a longitu-
dinal observation study that examined 367 samples obtained over a
10+ year period from six dolphins aged≥30 years, in which mean
glucose concentrations were reported to be 121–125 mg/dL, with
no significant changes associated with age (103). In the third study,
six bottlenose dolphins had fasting mean serum glucose concen-
trations of 194 and 160 mg/dL determined on separate occasions
prior to a feeding challenge (1). Although methodologies used in
the studies were slightly different, there is no obvious explanation
for the variation observed in the dolphin studies but it is difficult
to identify all potential factors that might influence a particular
metabolic end point. However, it is intriguing that while no cap-
tive population had a mean fasting glucose below 108 mg/dL, a
survey of 62 free-living bottlenose dolphins reported a substan-
tially lower mean glucose of 94 mg/dL in the study population
(135).
Similarly, the blood glucose of cats may vary unpredictably
under some experimental conditions. The propensity for rapid
development of hyperglycemia when handled or during inter-
ventions is a confounding factor that must be considered when
interpreting studies of glucose homeostasis in cats. Investigators
have addressed potential “stress hyperglycemia” by using behav-
ioral desensitization techniques to adapt subject cats to the exper-
imental situation prior to obtaining baseline sample (101, 136).
Nevertheless, mild to moderate elevation in serum glucose is a
well-recognized feline response to stress in clinical or research con-
ditions (101) that may complicate determinations of the “normal”
glucose level and glucose tolerance in the cat (101, 137).
DIET EFFECTS ON CARBOHYDRATE METABOLISM IN
DOMESTIC/CAPTIVE CARNIVORES
Diet is another factor that might be expected to influence carbohy-
drate metabolism in captive and free-living populations. A captive
or domestic carnivore may not consume a natural prey-based
diet and the substitute diet provided may not replicate exactly
the natural diet. The importance of diet for glucose homeostasis is
illustrated by the results from a study of captive cheetahs. Cheetahs
fed whole prey had different colonic short chain fatty acid profiles
and lower colonic propionate concentrations than when they were
fed meat alone (138). Colonic propionate can be used by felids as
a substrate for gluconeogenesis, as described in a study in the
domestic cat (139). There is also evidence that captivity may alter
diet choices and feeding ecology of dolphins. Captive dolphins are
maintained on a fish-based diet that approximates the free-living
diet but may substitute frozen fish/squid for live prey and supple-
ments may be needed to ensure the diet is nutritionally complete.
The source of protein (mackerel, herring, squid, etc.), the portion
fed, and the frequency of meals may be more uniform in captive
diets (140) whereas free-living individuals would encounter prey
at irregular intervals, have access to variable amounts of food, and
might vary the diet based on prey availability (141).
In cats, the wide variety of available commercial diets formu-
lated using different protein, fat, and carbohydrate compositions,
means that diet effects must be carefully controlled for in studies
of feline nutrient metabolism. Complete discussion of the com-
plex effect of diet composition on glycemia and metabolism in
cats exceeds the scope of this article but the subject has been sum-
marized in detail by others (7). However, pertinent observations
concerning possible diet effects on feline carbohydrate metabolism
merit a brief discussion. Although cats have no minimum dietary
carbohydrate requirement, they are able to effectively digest and
absorb diets containing large amounts of processed carbohydrates
(104). Digestive signs (diarrhea, gas production, altered motility
patterns) indicating dietary intolerance may occur when dietary
carbohydrate content exceeds 40% but these signs may reflect
osmotic and mechanical effects of large intraluminal sugar con-
centrations on gut function (18). Consumption of very low car-
bohydrate diets (7% total carbohydrate content) did not improve
glucose tolerance and insulin secretion in non-obese, healthy cats
when compared with consumption of diets containing about 25%
carbohydrate (142). At the other end of the spectrum, cats fed diets
containing 47% carbohydrate demonstrated increased serum glu-
cose (as measured by area-under-the-curve) after a meal but no
significant difference in insulin response. Finally is no evidence
that dietary carbohydrates cause feline obesity or diabetes (104).
In the cat, obesity is more related to total energy consumed than
to dietary composition (143, 144).
In the domestic cat, substantial elevations in blood glucose are
achieved during challenge tests, such as the intravenous glucose
tolerance test, due to the rapid injection of large amounts of glu-
cose, a simple carbohydrate (145–147). However, the dietary car-
bohydrate content does not strongly impact post-prandial blood
glucose in cats, except when the diet is directly supplemented
with glucose (21, 105). The relatively blunted rise in glucose after
feeding occurs because commercial feline diets, even those with
moderate carbohydrate level, contain complex rather than simple
carbohydrates (104). Complex carbohydrates have a slower rate of
digestion and absorption than simple sugars, like glucose, which
are rapidly absorbed from the intestine.
ACQUIRED DISORDERS OF CARBOHYDRATE METABOLISM IN
DOMESTIC/CAPTIVE CARNIVORES
Feline diabetes mellitus
Diabetes mellitus in the domestic cat is a frequently encountered
endocrinopathy in veterinary medicine but is probably rare in
free-living felids and other carnivores. Overt diabetes mellitus –
with hyperglycemia and severe insulin deficiency as prominent
features – can be considered a disorder of domestication in that
affected cats would die without treatment. Thus, among pet cats
and the myriad of other domestic and captive species in which
diabetes has been reported, the diabetes prevalence is a reflection
of the willingness and ability of veterinarians and pet owners to
provide care and treatment (148–154). Similarities in the clinical
presentation and treatment of naturally occurring feline diabetes
and human type 2 diabetes have already been noted. The patho-
physiology underlying the development and maintenance of the
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diabetic state in the domestic cats has reviewed in detail by oth-
ers, who have noted the strong parallels between carbohydrate and
lipid abnormalities in cats and humans with diabetes (155–158).
Dolphin hemochromatosis
Hemochromatosis is well documented in dolphins maintained in
captivity but is poorly documented in free-living dolphins. Sim-
ilarities between hemochromatosis of dolphins and humans has
already been discussed but there is evidence that hemochromatosis
is a disorder of captivity. A study comparing iron indices reported
that serum iron, ferritin, and transferrin saturation levels were
lower in free-living dolphins than in captive dolphins, suggesting
an association between iron disorders and captivity (120).
CONCLUSION: CARNIVORE CARBOHYDRATE METABOLISM
AS A MODEL FOR HUMAN DISEASES
Knowledge of the genetic, molecular, and physiologic mechanisms
that govern carnivore metabolism is incomplete, yet elucidation
of their unique metabolism is essential for understanding the
physiology, ecology, and husbandry of carnivore species and their
evolutionary adaptation to a specialized ecological niche. Like-
wise, the potential for carnivores to serve as comparative models
for human diabetes has yet to be fully realized. The similarities
between normal metabolic processes in carnivores and diabetes
pathology in humans suggest carnivores may be useful mod-
els for human type 2 diabetes. While no single animal model
completely reproduces the human disease, the dolphin and cat
models represent a unique opportunity to study important fea-
tures of human diabetes and offer several advantages as research
subjects. First, a major advantage is that diabetes does not have
to be induced because the metabolism of interest is present in
healthy animals. This avoids a drawback of many traditional ani-
mal diabetes models in which the disease must be induced, the
animals become clinically ill or require extensive treatment. Sec-
ond, compared with humans, normal carnivores appear to have
mild glucose intolerance and reduced insulin sensitivity, which
offers opportunity to study the metabolic pathways that under-
lie glucose intolerance and insulin resistance, two hallmarks of
diabetes pathology in humans. Third, the animals are long lived,
which permits study of individual animals over many years, easy
to maintain in a controlled environment, are cooperative, and
accessible for study.
Carnivores are remarkably adapted to their ecological niche as
predators (5, 7, 159–161). Carbohydrate metabolism of healthy
carnivores, such as the dolphin and cat, differs from metabo-
lism in healthy omnivores, such as humans, dogs, and rodents.
As discussed in this review, carnivore metabolism shares impor-
tant features with pathological changes observed in pre-diabetic
and diabetic humans. It is clear that carnivore metabolism is
adaptive, having evolved to facilitate efficient consumption of a
prey-based diet that is high in protein and low in carbohydrate con-
tent. Remarkably, the metabolic adaptations that sustain glucose
homeostasis in carnivores are maladaptive in humans, producing
insulin resistance and glucose intolerance and leading to myriad
undesirable metabolic consequences (100, 160). While much of
carnivore metabolism remains undiscovered, past work has pro-
vided a firm base from which to pursue new research into novel
metabolic pathways of carnivores and their unique role as models
for common metabolic disorders that affect humans.
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